Your session is about to expire
← Back to Search
Time-Restricted Eating for Cancer-Related Fatigue
N/A
Waitlist Available
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be at least 18 years old
Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, 'In the last week, how bad was your worst fatigue on a scale from 0-10?'
Must not have
Be taking insulin
Be on enteral or parenteral nutrition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess if a 12-week intervention of time-restricted eating, or TRF, could help reduce cancer-related fatigue. Participants will be randomly assigned to either the TRF intervention or a control group. The TRF group will select an 10-hour window to consume all food and beverages. The study will also explore if there is a relationship between fatigue, circadian rhythm, and glucose metabolism.
Who is the study for?
This trial is for cancer survivors who are at least 18 years old, have completed their main treatments between 2 months and 2 years ago, can use a smartphone, speak English, and consent to study procedures. They must feel fatigued (score of 4+ on a scale of 0-10) but not be underweight or have conditions like type 1 diabetes that could complicate the diet intervention.
What is being tested?
The study tests if restricting eating to a 10-hour window each day for 12 weeks reduces fatigue in cancer survivors compared to those receiving general health education. Participants will be randomly assigned to either time-restricted eating or control group in equal numbers.
What are the potential side effects?
Potential side effects may include hunger outside of the eating window, changes in energy levels throughout the day, possible headaches or irritability due to changes in usual eating patterns.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My worst fatigue level in the last week was 4 or higher on a scale of 0-10.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently taking insulin.
Select...
I am receiving nutrition through a feeding tube or IV.
Select...
I am scheduled for surgery during the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fatigue, as assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire
Feasibility, as assessed by the percentage of participants who enrolled completed the study
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Time-restricted eatingExperimental Treatment2 Interventions
Participants will self-select a 10-hour window in which to consume all food and beverages (with the exception of black coffee and unsweetened tea in the mornings; water is okay at all times). Participants will also receive weekly tips to encourage a healthy lifestyle in cancer survivorship.
Group II: ControlExperimental Treatment1 Intervention
Participants will receive weekly tips to encourage healthy lifestyle behaviors in cancer survivorship.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time-restricted eating
2022
N/A
~850
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
713 Previous Clinical Trials
379,442 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
366 Previous Clinical Trials
412,590 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently taking insulin.I do not have conditions like type 1 diabetes, risk for low blood sugar, specific medication needs, pregnancy, breastfeeding, or a recent eating disorder that would prevent me from following the study's diet plan.I am receiving nutrition through a feeding tube or IV.I am 18 years old or older.I am scheduled for surgery during the study.I finished my cancer treatment between 2 months and 2 years ago.My worst fatigue level in the last week was 4 or higher on a scale of 0-10.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger